← All Topics / ade

FDA ADE reports for Grapiprant — total reports, species & reaction breakdown

ade_grapiprant_adverse_events

ade 200 tok en 2026-07-21

Grapiprant — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Grapiprant is a veterinary active ingredient.

Total reports

Grapiprant: 8225

Reports by species (top entries)

  • Dog 7556
  • Cat 15
  • Human 13
  • Pig 1

Top reported reactions (VEDDRA terms, top entries)

  • Vomiting 1429
  • Diarrhoea 1257
  • Lack of efficacy - NOS 961
  • Lethargy (see also Central nervous system depression in 'Neurological') 659
  • Elevated alanine aminotransferase (ALT) 509
  • Death by euthanasia 479
  • Not eating 468
  • Decreased appetite 430
  • Bloody diarrhoea 392
  • Tablets, Abnormal 369

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21